BACKGROUND: Changes in the cortisol awakening response (CAR) were studied in women participating in a Mindfulness-Based Stress Reduction (MBSR) program after completion of their medical treatment for breast cancer. METHOD: Thirty-three women completed questionnaires pre- and post-MBSR pertaining to: stress, depressive symptomatology, and medical symptoms. The CAR was assessed on 3 days pre- and 3 days post-MBSR as a biological marker of stress. RESULTS: A significant effect on the CAR was found, with cortisol levels showing a prolonged increase after awakening at the post-MBSR assessment period. This was accompanied by significant improvements in self-reported stress levels, depressive symptomatology, and medical symptoms. Furthermore, the change in medical symptoms was negatively correlated with the area under the curve (AUC) at study onset (r = -.52, p < .002); i.e., the greater the AUC of the CAR before MBSR, the greater the reduction in medical symptoms after the program. CONCLUSIONS: These results suggest the potential usefulness of employing the CAR as a biological marker in women with breast cancer participating in an MBSR program.
BACKGROUND: Changes in the cortisol awakening response (CAR) were studied in women participating in a Mindfulness-Based Stress Reduction (MBSR) program after completion of their medical treatment for breast cancer. METHOD: Thirty-three women completed questionnaires pre- and post-MBSR pertaining to: stress, depressive symptomatology, and medical symptoms. The CAR was assessed on 3 days pre- and 3 days post-MBSR as a biological marker of stress. RESULTS: A significant effect on the CAR was found, with cortisol levels showing a prolonged increase after awakening at the post-MBSR assessment period. This was accompanied by significant improvements in self-reported stress levels, depressive symptomatology, and medical symptoms. Furthermore, the change in medical symptoms was negatively correlated with the area under the curve (AUC) at study onset (r = -.52, p < .002); i.e., the greater the AUC of the CAR before MBSR, the greater the reduction in medical symptoms after the program. CONCLUSIONS: These results suggest the potential usefulness of employing the CAR as a biological marker in women with breast cancer participating in an MBSR program.
Authors: Julie Loebach Wetherell; Hayley S Ripperger; Michelle Voegtle; Beau M Ances; David Balota; Emily S Bower; Colin Depp; Lisa Eyler; Erin R Foster; Denise Head; Tamara Hershey; Steven Hickman; Noralinda Kamantigue; Samuel Klein; J Philip Miller; Michael D Yingling; Jeanne Nichols; Ginger E Nicol; Bruce W Patterson; Thomas L Rodebaugh; Joshua S Shimony; Abraham Snyder; Mary Stephens; Susan Tate; Mary L Uhrich; David Wing; Gregory F Wu; Eric J Lenze Journal: Clin Trials Date: 2020-06-27 Impact factor: 2.486
Authors: Jennifer M Hulett; Jane M Armer; Emily Leary; Bob R Stewart; Roxanne McDaniel; Kandis Smith; Rami Millspaugh; Joshua Millspaugh Journal: Cancer Nurs Date: 2018 Mar/Apr Impact factor: 2.592
Authors: Rayna Kim Matsuno; Ian S Pagano; Gertraud Maskarinec; Brian F Issell; Carolyn C Gotay Journal: J Womens Health (Larchmt) Date: 2012-10-17 Impact factor: 2.681
Authors: Jan A Moynihan; Benjamin P Chapman; Rafael Klorman; Michael S Krasner; Paul R Duberstein; Kirk Warren Brown; Nancy L Talbot Journal: Neuropsychobiology Date: 2013-06-15 Impact factor: 2.328
Authors: Kavita D Chandwani; Julie L Ryan; Luke J Peppone; Michelle M Janelsins; Lisa K Sprod; Katie Devine; Lara Trevino; Jennifer Gewandter; Gary R Morrow; Karen M Mustian Journal: Evid Based Complement Alternat Med Date: 2012-07-15 Impact factor: 2.629